BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24.07.1997

Guidance for Industry: Changes To An Approved Application: Biological Products; Availability

The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled, ``Guidance for Industry: Changes To An Approved Application: Biological Products.'' The guidance document is intended to assist manufacturers in determining which reporting mechanism is appropriate for a change to an approved application, to reduce the burden on manufacturers of reporting changes, and to facilitate the approval process. The guidance document applies to all licensed biological products and establishments, including Whole Blood, blood components, Source Plasma, and Source Leukocytes, but not including specified biotechnology and specified synthetic biological products, or products formerly referred to as well-characterized therapeutic recombinant DNA-derived and monoclonal antibody biotechnology products. The guidance document announced in this notice revises the draft guidance entitled, ``Changes To An Approved Application; Draft Guidance,'' announced in the Federal Register of January 29, 1996 (61 FR 2749).

Source: Federal Register — Food and Drug AdministrationOpen original release →